Deutsche Bank’s RayzeBio, Inc. Common Stock RYZB Stock Holding History
Bought
Maintained
Sold
Deutsche Bank's RYZB Position: Q1 2024 in Review
Deutsche Bank sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 9,962 shares — an estimated $619K sold.
Deutsche Bank first reported a position in RYZB in Q4 2023 and held it in 1 quarter. The position peaked at $619K in Q4 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.
- Deutsche Bank reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Deutsche Bank sold 9,962 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $619K.
- Deutsche Bank first reported a position in RayzeBio, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
- Deutsche Bank's RayzeBio, Inc. Common Stock position peaked at $619K in Q4 2023.
- 0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.
Based on Deutsche Bank's 13F filing for Q1 2024, filed 15 May 2024.